DLGAP2-AS1

Across TCGA pan-cancer cohorts, DLGAP2-AS1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated DLGAP2-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher DLGAP2-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DLGAP2-AS1 expression acts as an unfavorable survival marker, although some lineages such as GBM and ESCA show a favorable association.

ACC, BLCA, and OV are the cancer types where DLGAP2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.120	0.772	<.001	63	view →
BLCA	OS	Tertile	All	0.143	0.693	<.001	54	view →
OV	OS	Tertile	IV	0.022	0.760	<.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
LIHC	OS	Tertile	III,IV	0.051	0.650	<.001	36	view →
GBM	DFS	Tertile	All	0.410	0.232	.009	27	view →
COAD	OS	Tertile	III,IV	0.163	0.791	.004	27	view →
HNSC	DFS	Tertile	All	0.495	0.638	.022	12	view →
PCPG	DFS	Tertile	All	0.533	0.876	.034	9	view →
READ	OS	Tertile	II,III,IV	0.638	0.914	.049	9	view →
ESCA	OS	Tertile	II,III,IV	0.752	0.404	.040	6	view →
THCA	OS	Tertile	All	0.810	0.940	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

DLGAP2-AS1–ACC (DFS)

Open the ACC breakdown →